Septerna (SEPN) Interest Expenses (2023 - 2026)
Septerna's (SEPN) quarterly Interest Expenses came in at $67.8 million in Q1 2026, up 1231.42% year-on-year from $5.1 million in Q1 2025, and down 22.25% quarter-over-quarter from $87.2 million in Q4 2025.
Septerna (SEPN) Interest Expenses (2023 - 2026) Analysis & Trends
Septerna's Interest Expenses history runs 4 years deep, the most recent figure standing at $67.8 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 1231.42% year-over-year to $67.8 million in Q1 2026; TTM through Mar 2026 was $67.8 million, a 1231.42% increase from a year earlier, with the FY2025 full-year figure at $87.2 million, up 62.35% from the prior year.
- Interest Expenses eased to $67.8 million in Q1 2026 per SEPN's latest filing, from $87.2 million in the prior quarter.
- Across five years, Interest Expenses topped out at $87.2 million in Q4 2025 and bottomed at $2.3 million in Q4 2023.
- The 4-year median for Interest Expenses is $35.6 million (2024), against an average of $37.4 million.
- Across the five-year window, Interest Expenses surged 1345.61% in 2024 and rose 29.1% in 2025, its largest moves.
- Year by year, Interest Expenses stood at $2.3 million in 2023, then jumped by 1345.61% to $33.1 million in 2024, then surged by 163.74% to $87.2 million in 2025, then decreased by 22.25% to $67.8 million in 2026.
- Per Business Quant, the three latest SEPN Interest Expenses figures stand at $67.8 million (Q1 2026), $87.2 million (Q4 2025), and $49.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Septerna | 1.48 Bn | 1.48 Bn | - | 67.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.80 Mn |
| Mar 31, 2026 | 67.80 Mn |
| Dec 31, 2025 | 87.19 Mn |
| Dec 31, 2025 | 87.19 Mn |
| Sep 30, 2025 | 49.20 Mn |
| Sep 30, 2025 | 49.20 Mn |
| Jun 30, 2025 | 16.77 Mn |
| Jun 30, 2025 | 16.77 Mn |
| Mar 31, 2025 | 5.09 Mn |
| Mar 31, 2025 | 5.09 Mn |
| Dec 31, 2024 | 33.06 Mn |
| Dec 31, 2024 | 33.06 Mn |
| Sep 30, 2024 | 38.11 Mn |
| Sep 30, 2024 | 38.11 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Dec 31, 2023 | 2.29 Mn |